cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Compugen Ltd
8 own
17 watching
Current Price
$2.4
$0
(0%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
109.77M
52-Week High
52-Week High
2.69000
52-Week Low
52-Week Low
0.53000
Average Volume
Average Volume
0.41M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
--
iconMarket Capitalization109.77M
icon52-Week High2.69000
icon52-Week Low0.53000
iconAverage Volume0.41M
iconDividend Yield--
iconP/E Ratio--
What does the Compugen Ltd do?
Compugen Ltd., a therapeutic discovery company, engages in the research, development, and commercialization of therapeutic and product candidates in Israel and Europe. The company's pipeline primarily includes early and preclinical stage immuno-oncology programs based on novel drug targets, such as immune checkpoint and myeloid protein target candidates to harness the immune system to provide treatment solutions in the areas of unmet medical needs in various cancer types and patient populations. Its antibody drug conjugate target candidates comprise CGEN-15001T, CGEN-15022, CGEN-15029, and CGEN-15137 for oncology; and therapeutic proteins include CGEN-15001, a fusion protein for autoimmune diseases, as well as CGEN myeloid target. The company was incorporated in 1993 and is headquartered in Holon, Israel.
Read More
News & Events about Compugen Ltd.
Zolmax
10 months ago
Compugen (NASDAQ:CGEN Get Rating) and Graphite Bio (NASDAQ:GRPH Get Rating) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their risk, institutional ownership, analyst recommendations, dividends, valuation, ...
Ticker Report
11 months ago
Compugen (NASDAQ:CGEN Get Rating) and Prime Medicine (NYSE:PRME Get Rating) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their risk, profitability, valuation, dividends, earnings, institutional ...
PR Newswire
11 months ago
Compugen Reports Fourth Quarter and Full Year 2022 Results Compugen Reports Fourth Quarter and Full Year 2022 Results PR Newswire HOLON, Israel, Feb. 27, 2023 On track to dose the first patients in MSS CRC and PROC triple combination proof of concept studies in Q1 2023 and Q2 2023, respectively...
Benzinga
12 months ago
read more...
Frequently Asked Questions
Frequently Asked Questions
What is Compugen Ltd share price today?
plus_minus_icon
Can Indians buy Compugen Ltd shares?
plus_minus_icon
How can I buy Compugen Ltd shares from India?
plus_minus_icon
Can Fractional shares of Compugen Ltd be purchased?
plus_minus_icon
What are the documents required to start investing in Compugen Ltd stocks?
plus_minus_icon
What is today’s traded volume of Compugen Ltd?
plus_minus_icon
What is today’s market capitalisation of Compugen Ltd?
plus_minus_icon
What is the 52-Week High and Low Range of Compugen Ltd?
plus_minus_icon
What percentage is Compugen Ltd down from its 52-Week High?
plus_minus_icon
What percentage is Compugen Ltd up from its 52-Week Low?
plus_minus_icon
Current Price
$2.4
$0
(0%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Get Started with as little as $1.00